Latin Clinical Trial Center | San Juan, PR

Research site
1801 Ponce de Leon Avenue, Suite 205-205A, San Juan, Puerto Rico, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


11 of 44
Status: Active
Trial type: Interventional
Funder type: Industry

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain (CPMP)

The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-s...

Chronic Low-back Pain
Diabetic Neuropathic Pain
Drug: LY3526318 ISA
Drug: LY3857210 ISA
Status recently updated

This study is researching an investigational drug called ALN-HSD (called "study drug"). This study is focused on participants who are known to have n...

Active, not recruiting
Non-alcoholic Steatohepatitis (NASH)
Metabolic Dysfunction Associated Steatohepatitis (MASH)
Drug: Placebo

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...

Active, not recruiting
Rheumatoid Arthritis
Drug: Baricitinib
Drug: TNF Inhibitor

The main purpose of this study is to determine the efficacy and safety of insulin efsitora alfa (LY3209590) administered weekly using a fixed dose es...

Active, not recruiting
Type 2 Diabetes
Drug: Insulin Glargine
Drug: Insulin Efsitora Alfa

The main purpose of this study is to assess efficacy and safety of orforglipron compared with oral semaglutide in participants with Type 2 diabetes a...

Type 2 Diabetes
Drug: Orforglipron
Drug: Semaglutide

The main purpose of this study is to assess the safety and efficacy of peresolimab in adult participants with moderately-to-severely active rheumatoi...

Active, not recruiting
Joint Diseases
Drug: Peresolimab
Drug: Placebo

The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and established cardiov...

Cardiovascular Diseases
Drug: Placebo
Drug: Retatrutide

This is a study of tirzepatide in participants with overweight and obesity. The main purpose is to learn more about how tirzepatide affects body weig...

Active, not recruiting
Drug: Tirzepatide
Drug: Placebo

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe System...

Systemic Lupus Erythematosus
Other: Placebo
Drug: Deucravacitinib

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Placebo
Drug: Inclisiran sodium 300 mg

The goals of this clinical study are to learn more about the study drugs, semaglutide (SEMA) with the fixed-dose combination (FDC) of cilofexor/firso...

Active, not recruiting
Nonalcoholic Steatohepatitis
Drug: Cilofexor (CILO)/Firsocostat (FIR)

Trial conditions

Fatty Liver (7 trials)
Non-alcoholic Fatty Live... (7 trials)
Diabetes Mellitus (6 trials)
Low Back Pain (5 trials)
Neuralgia (5 trials)
Osteoarthritis (5 trials)
Systemic Lupus Erythemat... (5 trials)
Type 2 Diabetes Mellitus (5 trials)
Arthritis (4 trials)
Back Pain (4 trials)

And 28 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems